William C. Shakespeare
2020
In 2020, William C. Shakespeare earned a total compensation of $1.6M as Co-Founder, President of Research and Development at Theseus Pharmaceuticals.
Compensation breakdown
Option Awards | $1,266,346 |
---|---|
Salary | $323,237 |
Total | $1,589,583 |
Shakespeare received $1.3M in option awards, accounting for 80% of the total pay in 2020.
Shakespeare also received $323.2K in salary.
Rankings
In 2020, William C. Shakespeare's compensation ranked 6,583rd out of 13,090 executives tracked by ExecPay. In other words, Shakespeare earned more than 49.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,583 out of 13,090 | 50th |
Division Manufacturing | 2,730 out of 5,624 | 52nd |
Major group Chemicals And Allied Products | 1,099 out of 2,257 | 51st |
Industry group Drugs | 953 out of 1,957 | 51st |
Industry Pharmaceutical Preparations | 712 out of 1,462 | 51st |
Source: SEC filing on April 25, 2022.
Shakespeare's colleagues
We found one more compensation record of an executive who worked with William C. Shakespeare at Theseus Pharmaceuticals in 2020.
2020
Iain MA
Theseus Pharmaceuticals